A major number of patients with cancer often go undiagnosed for acute and chronic hepatitis. A study conducted by investigators from SWOG Cancer Research Network demonstrated that a substantial portion of newly diagnosed cancer patients was unaware of the fact that they were infected with hepatitis virus due to unidentifiable risk factors. The above study was conducted between 2013 and 2017 at 18 different academic and community hospitals across the United States. A total of 3,051 newly detected cancer patients were enrolled.
The study participants were treated for the most common types of cancer, including malignancies of the breast, blood, bone marrow, colorectal and lung. These participants were tested for hepatitis B virus (HBV), hepatitis C virus (HCV) virus, and human immunodeficiency virus (HIV). Here’s what they found: 5% of patients had past HBV 6% had chronic HBV 4% had HCV…
